相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tapering Antipsychotic Treatment
Mark Abie Horowitz et al.
JAMA PSYCHIATRY (2021)
Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm
Chen-Chung Liu et al.
CNS DRUGS (2020)
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia
Stefan Leucht et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Risk factors for psychotic relapse after dose reduction or discontinuation of antipsychotics in patients with chronic schizophrenia. A systematic review and meta-analysis
Jan P A M Bogers et al.
SCHIZOPHRENIA BULLETIN (2020)
Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial
Aristotle N. Voineskos et al.
JAMA PSYCHIATRY (2020)
The 'patient voice': patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition
Anne Guy et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2020)
Outcome of antidepressant drug discontinuation with taperingstrips after 1-5 years
Peter C. Groot et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2020)
Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder
Joanna Moncrieff et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2020)
The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study
Sameer Jauhar et al.
BIOLOGICAL PSYCHIATRY (2019)
Psychiatric hospitalization following antipsychotic medication cessation in first episode psychosis
Joseph F. Hayes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Mental health professionals' views and experiences of antipsychotic reduction and discontinuation
Ruth E. Cooper et al.
PLOS ONE (2019)
Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
Robert A. McCutcheon et al.
TRENDS IN NEUROSCIENCES (2019)
Tapering of SSRI treatment to mitigate withdrawal symptoms
Mark Abie Horowitz et al.
LANCET PSYCHIATRY (2019)
Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis
Robert McCutcheon et al.
SCHIZOPHRENIA BULLETIN (2018)
20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia
Jari Tiihonen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Historical perspectives on tardive dyskinesia
Stanley N. Caroff et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Increasing expectations and knowledge require a more subtle use of prophylactic antipsychotics
Robin M. Murray et al.
WORLD PSYCHIATRY (2018)
Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review
Meghan Bowtell et al.
SCHIZOPHRENIA RESEARCH (2018)
Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis
Maren Carbon et al.
WORLD PSYCHIATRY (2018)
SSRI and SNRI withdrawal symptoms reported on an internet forum
Tom Stockmann et al.
INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE (2018)
Five Year Outcomes of Tapering Antipsychotic Drug Doses in a Community Mental Health Center
Sandra Steingard
COMMUNITY MENTAL HEALTH JOURNAL (2018)
The least worst option: user experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample
Nicola Morant et al.
JOURNAL OF MENTAL HEALTH (2018)
Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial
Claudi L. H. Bockting et al.
LANCET PSYCHIATRY (2018)
Relapse After Antipsychotic Discontinuation in Schizophrenia as a Withdrawal Phenomenon vs Illness Recurrence: A Post Hoc Analysis of a Randomized Placebo-Controlled Study
Robin Emsley et al.
JOURNAL OF CLINICAL PSYCHIATRY (2018)
Maintenance antipsychotic treatment versus discontinuation strategies following remission from first episode psychosis: systematic review
Andrew Thompson et al.
BJPSYCH OPEN (2018)
Does Half-Life Matter After Antipsychotic Discontinuation? A Relapse Comparison in Schizophrenia With 3 Different Formulations of Paliperidone
Peter J. Weiden et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Guy Chouinard et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2017)
Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-Episode Nonaffective Psychosis Individuals: A 3-Year Naturalistic Follow-Up Study
Jacqueline Mayoral-van Son et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
Robin M. Murray et al.
BRITISH JOURNAL OF PSYCHIATRY (2016)
Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era
M. Alvarez-Jimenez et al.
CNS DRUGS (2016)
The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies
Antonio Vita et al.
BIOLOGICAL PSYCHIATRY (2015)
Antipsychotic Maintenance Treatment: Time to Rethink?
Joanna Moncrieff
PLOS MEDICINE (2015)
De novo treatment-resistant psychosis following thioridazine withdrawal
Tarun Bastiampillai et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2014)
Withdrawal Symptoms and Rebound Syndromes Associated with Switching and Discontinuing Atypical Antipsychotics: Theoretical Background and Practical Recommendations
Anja Cerovecki et al.
CNS DRUGS (2013)
Estimating Dopamine D2 Receptor Occupancy for Doses of 8 Antipsychotics A Meta-Analysis
Irene M. Lako et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Stefan Leucht et al.
LANCET (2013)
Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies
John M. Kane et al.
WORLD PSYCHIATRY (2013)
Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy Long-term Follow-up of a 2-Year Randomized Clinical Trial
Lex Wunderink et al.
JAMA PSYCHIATRY (2013)
Antipsychotic Medication During the Critical Period Following Remission From First-Episode Psychosis Less Is More
Patrick McGorry et al.
JAMA PSYCHIATRY (2013)
Psychotropic discontinuation leading to an NMS-like condition
Renjith Kurien et al.
PROGRESS IN NEUROLOGY AND PSYCHIATRY (2013)
The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
Oliver D. Howes et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Adolescent female with withdrawal psychosis following abrupt termination of ziprasidone
Maryann K. Jacob et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2012)
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
Stefan Leucht et al.
LANCET (2012)
Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis
Shigenori Tadokoro et al.
SCHIZOPHRENIA BULLETIN (2012)
Antipsychotic treatment for schizophrenia in the maintenance phase: A systematic review of the guidelines and algorithms
Hiroyoshi Takeuchi et al.
SCHIZOPHRENIA RESEARCH (2012)
Antipsychotics, dopamine D2 receptor occupancy and clinical improvement in schizophrenia: A meta-analysis
Zeynep Yilmaz et al.
SCHIZOPHRENIA RESEARCH (2012)
Domperidone-Induced Tardive Dyskinesia and Withdrawal Psychosis in an Elderly Woman with Dementia
Jessika Roy-Desruisseaux et al.
ANNALS OF PHARMACOTHERAPY (2011)
Antipsychotic prophylaxis is needed after remission from a first psychotic episode in schizophrenia patients: Results from an aborted randomised trial
Geartsje Boonstra et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2011)
Relapse Prevention in First-Episode Schizophrenia-Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention: Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia
Wolfgang Gaebel et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Predicting Dopamine D2 Receptor Occupancy From Plasma Levels of Antipsychotic Drugs A Systematic Review and Pooled Analysis
Hiroyuki Uchida et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Effects of antipsychotics on D3 receptors: A clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO
Romina Mizrahi et al.
SCHIZOPHRENIA RESEARCH (2011)
What do individuals with schizophrenia need to increase their well-being
Petra Gunnmo et al.
INTERNATIONAL JOURNAL OF QUALITATIVE STUDIES ON HEALTH AND WELL-BEING (2011)
Drug Discontinuation Effects Are Part of the Pharmacology of a Drug
Marcus M. Reidenberg
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Potential Adverse Effects of Discontinuing Psychotropic Drugs-Part 4: Benzodiazepine, Glutamate, Opioid, and Stimulant Drugs
Robert H. Howland
JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES (2010)
Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial
Eric Y. H. Chen et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study
M. A. Franks et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Discontinuing medications: A novel approach for revising the prescribing stage of the medication-use process
Kevin T. Bain et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes
Guy Chouinard et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2008)
Atypical antipsychotic withdrawal dyskinesia in 4 patients with mood disorders
Maria Urbano et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Guide discontinuaton vesus maintenance treatment in remitted first-episode psychosis: Relapse rates and functional outcome
Lex Wunderink et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Breakthrough dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time
Anne-Noel Samaha et al.
JOURNAL OF NEUROSCIENCE (2007)
Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse
J. Moncrieff
ACTA PSYCHIATRICA SCANDINAVICA (2006)
The diagnosis and management of benzodiazepine dependence
H Ashton
CURRENT OPINION IN PSYCHIATRY (2005)
Determining the optimal dose of haloperidol in first-episode psychosis
P Oosthuizen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2001)
D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment:: Influence of withdrawal period
JN Joyce
SYNAPSE (2001)
Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?:: A new hypothesis
S Kapur et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Receptor regulation as a unitary mechanism for drug tolerance and physical dependence - not quite as simple as it seemed!
J Littleton
ADDICTION (2001)
Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans:: a clinical PET study
S Silvestri et al.
PSYCHOPHARMACOLOGY (2000)
Relationship between dopamine D2 occupancy, clinical response, and side effects:: A double-blind PET study of first-episode schizophrenia
S Kapur et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
分享论文
